CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Ziopharm Oncology, Inc. Company Snapshot
Ziopharm Oncology, Inc. operates within the Specialty outpatient clinics sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ziopharm Oncology with three other health care providers in North America: Catasys Inc (2016 sales of $7.08 million ), Grow Solutions Holdings Inc ($6.78 million ), and Pacific Health Care Organization, Inc. ($5.69 million ).

Sales Analysis. During the year ended December of 2016, sales at Ziopharm Oncology were $6.86 million. This is an increase of 58.4% versus 2015, when the company's sales were $4.33 million. This was the third consecutive year of growth at Ziopharm Oncology.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Ziopharm Oncology, Inc.
  Stock Performance Chart for Ziopharm Oncology, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (9/15/2017): 6.21
(Figures in U.S. Dollars)
1 Week 0.5%   13 Weeks 24.4%  
4 Weeks 15.6%   52 Weeks 12.9%  
 
Ziopharm Oncology, Inc. Key Data:
  Ticker: ZIOP Country: United States
  Exchanges: NAS Major Industry: Health Care Equipment & Services
    Sub Industry: Specialty Outpatient Clinics
  2016 Sales 6,861,000
(Year Ending Jan 2017).
Employees: 43
  Currency: U.S. Dollars Market Cap: 881,588,920
  Fiscal Yr Ends: December Shares Outstanding: 141,962,789
  Share Type: Common Closely Held Shares: 2,220,234
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.